{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T02:45:37Z","timestamp":1767494737005},"publisher-location":"Berlin, Heidelberg","reference-count":33,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642701429"},{"type":"electronic","value":"9783642701405"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1985]]},"DOI":"10.1007\/978-3-642-70140-5_2","type":"book-chapter","created":{"date-parts":[[2011,10,25]],"date-time":"2011-10-25T18:06:39Z","timestamp":1319565999000},"page":"9-18","source":"Crossref","is-referenced-by-count":78,"title":["Receptor-Binding Profiles of Neuroleptics"],"prefix":"10.1007","author":[{"given":"J.","family":"Hyttel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-J.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. V.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Arnt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"2_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0014-2999(81)90608-7","volume":"69","author":"J Arnt","year":"1981","unstructured":"Arnt J, Christensen AV (1981) Differential reversal by scopolamine and THIP of the antistereotypic and cataleptic effects of neuroleptics. Eur J Pharmacol 69: 107\u2013111","journal-title":"Eur J Pharmacol"},{"key":"2_CR2","first-page":"1331","volume":"20","author":"J Arnt","year":"1981","unstructured":"Arnt J, Christensen AV, Hyttel J (1981) Differential reversal by scopolamine of effects of neuroleptics in rats. Relevance for evaluation of therapeutic and extrapyramidal side-effect potential. Neuropharmacology 20: 1331\u20131334","journal-title":"Neuropharmacology"},{"key":"2_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/0014-2999(84)90267-X","volume":"102","author":"J Arnt","year":"1984","unstructured":"Arnt J, Hyttel J (1984) Differential inhibition by dopamine D-l and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions. Eur J Pharmacol 102: 349\u2013354","journal-title":"Eur J Pharmacol"},{"key":"2_CR4","first-page":"828","volume-title":"Biological psychiatry","author":"AV Christensen","year":"1981","unstructured":"Christensen AV (1981) Dopamine hyperactivity: effects of neuroleptics alone or in combination with GABA-agonists. In: Perris C, Struwe G, Jansson B (eds) Biological psychiatry. Elsevier, Amsterdam, pp 828\u2013832"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/0024-3205(79)90010-9","volume":"24","author":"AV Christensen","year":"1979","unstructured":"Christensen AV, Arnt J, Scheel-Kriiger J (1979) Decreased antistereotypic effect of neuroleptics after additional treatment with a benzodiazepine, a GABA agonist and an anticholinergic compound. Life Sci 24: 1395\u20131402","journal-title":"Life Sci"},{"issue":"2","key":"2_CR6","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/0361-9230(80)90149-5","volume":"5","author":"AV Christensen","year":"1980","unstructured":"Christensen AV, Arnt J, Scheel-Kriiger J (1980) GABA-dopamine\/neuroleptic interaction after systemic administration. Brain Res Bull 5 [Suppl 2]: 885\u2013890","journal-title":"Brain Res Bull"},{"key":"2_CR7","first-page":"329","volume":"3","author":"AV Christensen","year":"1982","unstructured":"Christensen AV, Hyttel J (1982) Neuroleptics and the clinical implications of adaptation of dopamine neurons. Pharmacy Int 3: 329\u2013332","journal-title":"Pharmacy Int"},{"key":"2_CR8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1126\/science.3854","volume":"192","author":"I Creese","year":"1976","unstructured":"Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192: 481\u2013483","journal-title":"Science"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/BF00432676","volume":"74","author":"AJ Cross","year":"1981","unstructured":"Cross AJ, Crow TJ, Owen F (1981) 3H-flupenthixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in D2 receptors. Psychophamacology 74: 122\u2013124","journal-title":"Psychophamacology"},{"key":"2_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1192\/bjp.134.3.249","volume":"134","author":"TJ Crow","year":"1979","unstructured":"Crow TJ, Baker HF, Cross AJ, Joseph MH, Lofthouse R, Longden A, Owen F, Riley GJ, Glover V, Killpack WS (1979) Monoamine mechanisms in chronic schizophrenia: postmortem neurochemical findings. Br J Psychiatry 134: 249\u2013256","journal-title":"Br J Psychiatry"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/00004714-198210000-00010","volume":"2","author":"TJ Crow","year":"1982","unstructured":"Crow T J, Cross A J, Johnstone EC, Owen F, Owens DGC, Waddington JL (1982) Abnormal involuntary movements in schizophrenia: are they related to the disease process or J. Hyttel et al. treatment? Are they associated with changes in dopamine receptors? J Clin Psychopharmacol 2: 336\u2013340","journal-title":"J Clin Psychopharmacol"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1016\/0006-2952(83)90397-0","volume":"19","author":"S Fleminger","year":"1983","unstructured":"Fleminger S, Rupniak NMJ, Hall MD, Jennep, Marsden CD (1983) Changes in apomorphineinduced stereotypy as a result of subacute neuroleptic treatment correlate with increased D-2 receptors, but not with increases in D-l receptors. Biochem Pharmacol 19: 2921\u20132927","journal-title":"Biochem Pharmacol"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/0024-3205(78)90033-4","volume":"23","author":"J Hyttel","year":"1978","unstructured":"Hyttel J (1978) Effects of neuroleptics on 3H-haloperidol and 3H-cis(Z)-flupenthixol binding and on adenylate cyclase activity in vitro. Life Sci 23: 551\u2013556","journal-title":"Life Sci"},{"key":"2_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/0024-3205(81)90150-8","volume":"28","author":"J Hyttel","year":"1981","unstructured":"Hyttel J (1981) Similarities between the binding of 3H-piflutixol and 3H-flupentixol to rat striatal dopamine receptors in vitro. Life Sci 28: 563\u2013569","journal-title":"Life Sci"},{"key":"2_CR15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/B978-0-08-027391-4.50017-4","volume-title":"Advances in dopamine research","author":"J Hyttel","year":"1982","unstructured":"Hyttel J (1982) Preferential labelling of adenylate cyclase coupled dopamine receptors with thioxanthene neuroleptics. In: Kohsaka M, Shomori T, Tsukada Y, Woodruff GN (eds) Advances in dopamine research. Pergamon, Oxford, pp 147\u2013152 (Advances in the biosciences, vol 37 )"},{"key":"2_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0014-2999(83)90381-3","volume":"91","author":"J Hyttel","year":"1983","unstructured":"Hyttel J (1983) SCH 23390 \u2014 The first selective dopamine D-l antagonist. Eur J Pharmacol 91: 153\u2013154","journal-title":"Eur J Pharmacol"},{"key":"2_CR17","first-page":"157","volume":"18","author":"J Hyttel","year":"1983","unstructured":"Hyttel J, Christensen AV (1983) Biochemical and pharmacological differentiation of neuroleptic effect on dopamine D-l and D-2 receptors. J Neural Transm [Suppl] 18: 157\u2013164","journal-title":"J Neural Transm"},{"key":"2_CR18","doi-asserted-by":"crossref","unstructured":"Hyttel J, Christensen AV, Arnt J (1983) Neuroleptic classification: implications for tardive dyskinesia. In: Bannet J, Belmaker RH (eds) New directions in tardive dyskinesia research. Mod Probl Pharmacopsychiatry 21: 49\u201364","DOI":"10.1159\/000408483"},{"key":"2_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/277093a0","volume":"277","author":"JW Kebabian","year":"1979","unstructured":"Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277: 93\u201396","journal-title":"Nature"},{"key":"2_CR20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1176\/ajp.137.2.191","volume":"137","author":"T Lee","year":"1980","unstructured":"Lee T, Seeman P (1980a) Elevation of brain neuroleptic\/dopamine receptors in schizophrenia. Am J Psychiatry 137: 191\u2013197","journal-title":"Am J Psychiatry"},{"key":"2_CR21","first-page":"435","volume-title":"Receptors for neurotransmitters and peptide hormones","author":"T Lee","year":"1980","unstructured":"Lee T, Seeman P (1980b) Abnormal neuroleptic\/dopamine receptors in schizophrenia. In: Pepeu G, Kuhar MJ, Enna SJ (eds) Receptors for neurotransmitters and peptide hormones. Raven, New York, pp 435\u2013442"},{"key":"2_CR22","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/274897a0","volume":"274","author":"T Lee","year":"1978","unstructured":"Lee T, Seeman P, Tourtellotte WW, Farley IJ, Hornykeiwicz O (1978) Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains. Nature 274: 897\u2013900","journal-title":"Nature"},{"key":"2_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0014-2999(81)90434-9","volume":"70","author":"S Leff","year":"1981","unstructured":"Leff S, Lynne A, Hyttel J, Creese I (1981) Kainate lesion dissociates striatal dopamine radio-ligand binding sites. Eur J Pharmacol 70: 71\u201375","journal-title":"Eur J Pharmacol"},{"key":"2_CR24","first-page":"21","volume-title":"Janssenpharmas III psykiatersymposium","author":"J Leysen","year":"1982","unstructured":"Leysen J (1982) New discoveries in brain receptor research. Receptor binding properties of neuroleptics. In: Lauridsen B, Bech P (eds) Janssenpharmas III psykiatersymposium, Fossum Tryk, Birkerod, pp 21\u201326"},{"key":"2_CR25","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1126\/science.6310753","volume":"221","author":"M Memo","year":"1983","unstructured":"Memo M, Kleiman JE, Hanbauer I (1983) Coupling of dopamine Dx recognition sites with adenylate cyclase in nuclei accumbens and caudatus of schizophrenics. Science 221: 1304\u20131307","journal-title":"Science"},{"key":"2_CR26","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/BF00427697","volume":"82","author":"AG Molloy","year":"1984","unstructured":"Molloy AG, Waddington JL (1984) Dopaminergic behavior stereospecifically promoted by the Dt agonist R-SK & F 38393 and selectively blocked by the Dt antagonist SCH 23390. Psychopharmacology 82: 409\u2013410","journal-title":"Psychopharmacology"},{"key":"2_CR27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0024-3205(84)90116-4","volume":"35","author":"M Nielsen","year":"1984","unstructured":"Nielsen M, Klimek V, Hyttel J (1984) Distinct target size of dopamine D-l and D-2 receptors in rat striatum. Life Sci 35: 325\u2013332","journal-title":"Life Sci"},{"key":"2_CR28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0014-2999(84)90663-0","volume":"105","author":"KM O\u2019Boyle","year":"1984","unstructured":"O\u2019Boyle KM, Waddington JL (1984) Loss of rat striatal dopamine receptors with ageing is selective for D-2 but not D-l sites: association with increased non-specific binding of the D-l ligand [3H] piflutixol. Eur J Pharmacol 105: 171\u2013179","journal-title":"Eur J Pharmacol"},{"key":"2_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0140-6736(78)91740-3","volume":"11","author":"F Owen","year":"1978","unstructured":"Owen F, Cross AJ, CrowTJ, LongdenA, Poulter M, Riley GJ (1978) Increased dopamine-receptors sensitivity in schizophrenia. Lancet 11: 223\u2013225","journal-title":"Lancet"},{"key":"2_CR30","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1176\/ajp.137.12.1518","volume":"137","author":"SJ Peroutka","year":"1980","unstructured":"Peroutka SJ, Snyder SH (1980) Relationship of neuroleptic drug effects at brain dopamine, serotonin, a-adrenergic, and histamine receptors to clinical potency. Am J Psychiatry 137: 1518\u20131522","journal-title":"Am J Psychiatry"},{"key":"2_CR31","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/0024-3205(83)90155-8","volume":"33","author":"H Rosengarten","year":"1983","unstructured":"Rosengarten H, Schweitzer JW, Friedhoff AJ (1983) Induction of oral dyskinesias in naive rats by D1 stimulation. Life Sci 33: 2479\u20132482","journal-title":"Life Sci"},{"key":"2_CR32","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0006-8993(82)90420-6","volume":"250","author":"JC Stoof","year":"1982","unstructured":"Stoof JC, Kebabian JW (1982) Independent in vitro regulation by the D-2 dopamine receptor of dopamine-stimulated efflux of cyclic AMP and K+-stimulated release of acetylcholine from rat neostriatum. Brain Res 250: 263\u2013270","journal-title":"Brain Res"},{"key":"2_CR33","first-page":"165","volume-title":"Dopamine receptor agonists 1. Acta Pharm Suec [Suppl]","author":"U Ungerstedt","year":"1983","unstructured":"Ungerstedt U, Herrera-Marschitz M, Stahle L, Tossmann U, Zetterstrom T (1983) Dopamine receptor mechanisms studied by correlating transmitter release and behavior. In: Carlsson A, Nilsson JLG (eds) Dopamine receptor agonists 1. Acta Pharm Suec [Suppl] 1: 165\u2013181"}],"container-title":["Psychopharmacology Supplementum","Dyskinesia"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-70140-5_2.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T22:45:04Z","timestamp":1606257904000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-70140-5_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985]]},"ISBN":["9783642701429","9783642701405"],"references-count":33,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-70140-5_2","relation":{},"ISSN":["0931-6795"],"issn-type":[{"type":"print","value":"0931-6795"}],"subject":[],"published":{"date-parts":[[1985]]}}}